TCM Biotech International (ROCO:4169) EPS (Basic) : NT$0.36 (TTM As of Dec. 2024)

View and export this data going back to 2012. Start your Free Trial

What is TCM Biotech International EPS (Basic)?

TCM Biotech International's basic earnings per share (Basic EPS) for the six months ended in Dec. 2024 was NT$0.19. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was NT$0.36.

TCM Biotech International's EPS (Diluted) for the six months ended in Dec. 2024 was NT$0.19. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was NT$0.36.

TCM Biotech International's EPS without NRI for the six months ended in Dec. 2024 was NT$0.19. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was 0.35.

During the past 3 years, the average EPS without NRI Growth Rate was 111.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was 19.40% per year. During the past 10 years, the average EPS without NRI Growth Rate was -8.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, TCM Biotech International's highest 3-Year average EPS without NRI Growth Rate was 111.50% per year. The lowest was -57.50% per year. And the median was 11.30% per year.

TCM Biotech International EPS (Basic) Historical Data

The historical data trend for TCM Biotech International's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TCM Biotech International EPS (Basic) Chart

TCM Biotech International Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

Get a 7-Day Free Trial

0.50

0.04

0.37

0.35

0.36

TCM Biotech International Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EPS (Basic)	Get a 7-Day Free Trial															0.11	0.18	0.17	0.17	0.19

TCM Biotech International EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

TCM Biotech International's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(21.01	-	0)	/	58.361
	=	0.36

TCM Biotech International's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(11.157	-	0)	/	57.673
	=	0.19

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$0.36

TCM Biotech International (ROCO:4169) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

TCM Biotech International EPS (Basic) Related Terms

Thank you for viewing the detailed overview of TCM Biotech International's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

TCM Biotech International Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TCM Biotech International Corp (ROCO:4169) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 97, Section 1, Xintai 5th Road, 24th Floor-8, Xizhi District, Neihu District, Taipei, TWN, 221

Website

http://www.tcmbio.com

TCM Biotech International Corp is a Taiwan based biotechnology company. It is engaged in the research and development of therapeutics for the prevention and treatment of liver diseases. Its products includes Anti-adhesion System, Anti-neoplastic agents, Osteoporosis Treatment Preparation, Iron Preparations, Osteoarthritis (OA) Treatment Products, Urinary System Treatment Products and others. The company has a business presence in Taiwan and other international countries such as the United States, Japan, Singapore, Malaysia, Vietnam, the Philippines and China. The entity derives key revenue from the sales of multiple medical products which includes medicine, medical device, functional food and others.

TCM Biotech International Headlines

No Headlines